Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
RESPONSE GENETICS INC
| Metric | RESPONSE GENETICS INC Healthcare |
|---|---|
| Quality Score | 23 / 100 |
| Revenue (latest) | $17M |
| Net income (latest) | −$14M |
| Operating margin | −77.8% |
| Net margin | −81.9% |
| Return on equity | −548.0% |
| Return on assets | −101.9% |
| Return on capital (ROCE) | −154.9% |
| Debt / equity | 5.85× |
| Revenue growth (YoY) | −15.6% |
| Altman Z″ (distress) | -22.47 |
| Accruals / assets | 4.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.